The differential expression and function of these factors during effector and memory stages suggest an important role for them in the induction and maintenance of genetic programs that regulate effector and memory CD8+ T cell differentiation and imply that its use may greatly benefit tumor therapy. Here, CD8A is linked to neoplasm.